These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3019596)

  • 1. Number of "high genes" involved in determining the activity of paraoxonase.
    Nielsen A; Eiberg H; Fenger K; Mohr J
    Clin Genet; 1986 Jul; 30(1):41-9. PubMed ID: 3019596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number of loci responsible for the inheritance of high and low activity of paraoxonase.
    Nielsen A; Eiberg H; Mohr J
    Clin Genet; 1986 Mar; 29(3):216-21. PubMed ID: 3009059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution of different phenotypes of paraoxonase in a French population].
    Vincent-Viry M; La Du BN; Lepage L; Mikstacki T
    Ann Biol Clin (Paris); 1986; 44(3):233-8. PubMed ID: 3024528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of paraoxonase.
    Eiberg H; Mohr J
    Ann Hum Genet; 1981 Oct; 45(4):323-30. PubMed ID: 6282178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human serum paraoxonase/arylesterase polymorphism.
    Eckerson HW; Wyte CM; La Du BN
    Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paraoxonase polymorphism in a Saudi Arabian population.
    Nogueira CP; Evans DA; La Du BN
    Pharmacogenetics; 1993 Jun; 3(3):144-9. PubMed ID: 8392888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the serum paraoxonase/arylesterase polymorphism in some Sudanese families.
    La Du BN; Adkins S; Bayoumi RA
    Prog Clin Biol Res; 1986; 214():87-98. PubMed ID: 3014550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the polymorphism and ethnic distribution differences of human serum paraoxonase.
    Geldmacher-von Mallinckrodt M; Diepgen TL; Duhme C; Hommel G
    Am J Phys Anthropol; 1983 Nov; 62(3):235-41. PubMed ID: 6318563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphic paraoxonase/arylesterase isozymes of human serum.
    La Du BN; Eckerson HW
    Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.
    Mueller RF; Hornung S; Furlong CE; Anderson J; Giblett ER; Motulsky AG
    Am J Hum Genet; 1983 May; 35(3):393-408. PubMed ID: 6305189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
    Eckerson HW; Romson J; Wyte C; La Du BN
    Am J Hum Genet; 1983 Mar; 35(2):214-27. PubMed ID: 6301268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage between the loci for cystic fibrosis and paraoxonase.
    Schmiegelow K; Eiberg H; Tsui LC; Buchwald M; Phelan PD; Williamson R; Warwick W; Niebuhr E; Mohr J; Schwartz M
    Clin Genet; 1986 May; 29(5):374-7. PubMed ID: 3017612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human paraoxonase polymorphism: Hungarian population studies in children and adults.
    Szabó I; Róna K; Czinner A; Gachályi B
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):238-41. PubMed ID: 1651288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase polymorphism in three populations of southeast Asia.
    Roy AC; Saha N; Tay JS; Ratnam SS
    Hum Hered; 1991; 41(4):265-9. PubMed ID: 1664414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
    La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
    Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphism of human serum paraoxonase].
    Róna K; Szabó I; Gachályi B; Czinner A; Káldor A
    Orv Hetil; 1987 Nov; 128(47):2469-72. PubMed ID: 2827088
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
    Saha N; Roy AC; Teo SH; Tay JS; Ratnam SS
    Clin Genet; 1991 Oct; 40(4):277-82. PubMed ID: 1661643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny.
    Eiberg H; Mohr J; Schmiegelow K; Nielsen LS; Williamson R
    Clin Genet; 1985 Oct; 28(4):265-71. PubMed ID: 2998653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human serum paraoxonase/arylesterase polymorphism.
    La Du BN
    Am J Hum Genet; 1988 Sep; 43(3):227-9. PubMed ID: 2843045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.